Does Schedule III End 280E for Dispensaries in 2026?

Does Schedule III end 280E for dispensaries?

Only for state-licensed medical operators. The April 2026 final order moved medical marijuana and FDA-approved cannabis drug products to Schedule III, and because Section 280E applies only to Schedule I and Schedule II substances, it stopped reaching them. Adult-use cannabis remains Schedule I, so recreational dispensary sales are still fully subject to 280E.

Last updated August 2026. This is general information for licensed operators, not tax or legal advice. Tax positions turn on facts this page cannot know, and part of what follows describes guidance that has been announced but not yet issued. Confirm anything load-bearing with a cannabis-experienced accountant before you file.

What actually changed in April 2026

On April 23, 2026 the Attorney General issued a final order rescheduling marijuana from Schedule I to Schedule III. It was published in the Federal Register on April 28, 2026 and took effect on publication.

The order is narrower than most of the coverage suggested. It reaches two categories: cannabis drug products approved by the Food and Drug Administration, and marijuana held under a state-issued license to manufacture, distribute or dispense for medical purposes. That second category is the one that matters to dispensaries, and the word doing the work in it is medical.

Section 280E denies deductions and credits to any business trafficking in controlled substances listed in Schedule I or Schedule II. It is written by reference to the schedule, not to cannabis by name. So nothing had to be repealed for the relief to happen. Once state-licensed medical marijuana became a Schedule III substance, the statute simply no longer described it, and those operators can now deduct ordinary business expenses alongside cost of goods sold for the first time since the industry began.

Why recreational dispensaries got nothing

Adult-use cannabis was not included in the order and remains a Schedule I substance. 280E therefore continues to apply to recreational activity in full, exactly as it did before.

This is the sentence missing from most of the celebration in April, and it matters because adult-use is the larger share of US dispensary revenue. If your shop holds only a recreational license, your federal tax position today is identical to what it was in March 2026. Cost of goods sold is still the only route to reducing taxable income, and every dollar of rent, payroll, marketing and general overhead is still disallowed.

The broader question is genuinely open rather than resolved. The Drug Enforcement Administration held a rescheduling hearing on marijuana generally from June 29 to July 15, 2026. The chief administrative law judge set August 17, 2026 as the deadline for post-hearing briefs, capped at fifty pages, after which a recommended decision goes to the DEA Administrator, who is not bound to follow it. No statutory deadline governs the final decision. Any timeline you read for adult-use relief is a forecast, not a schedule, and a business plan that depends on one arriving by a particular quarter is not a plan.

When does the relief start? The transition rule question

The order was effective April 28, 2026, which raises an obvious and expensive question for a medical operator: does that mean allocating a year's expenses across a mid-year boundary?

Probably not, and this is the most practically valuable detail available right now. Treasury and the IRS announced a process for issuing tax guidance following the final order, and the guidance is expected to include a transition rule providing that rescheduling first applies for a business's full taxable year that includes the effective date. For a calendar-year taxpayer, that would put 280E relief back to January 1, 2026 rather than late April, and would remove the need to split a single tax year into pre-rescheduling and post-rescheduling periods.

Read that with the caveat attached, because the caveat is the honest part. As of August 2026 this is announced and anticipated, not published in final form. The sources describing the transition rule are reporting what Treasury has signalled it intends to do. That is a strong indication and worth planning around, but it is not issued guidance, and anyone presenting the mechanics as settled is ahead of the record. Keep records that would support either treatment until the final version exists.

The part nobody mentions: this made dual-license bookkeeping harder

Here is the twist that most owners discover only when they sit down with their accountant. For a large share of established dispensaries, rescheduling did not simplify the books. It split them.

Most shops in mature markets hold both a medical and an adult-use license and serve both from one building, with the same staff, the same lease, the same point of sale and the same utility bills. Before April 2026, all of that was uniformly non-deductible. That was punishing, but it was unambiguous: one regime, nothing to allocate, no judgment calls about which activity a given cost supported.

After April, one revenue stream carries ordinary deductions and the other does not. Every shared cost in that building now has to be divided between two federal tax regimes on a basis you can defend years later. That is a harder accounting problem than the one 280E used to pose, not an easier one, and it is not the problem most dispensary chart-of-accounts structures were built to answer.

The design implication is concrete. A 280E-aware chart of accounts has one axis, separating inventoriable cost from disallowed operating expense. The 2026 version needs two, because each expense has to be classified both by its nature and by which license generated the revenue it supported. If your books cannot currently produce a defensible medical versus adult-use split of rent and payroll for a single month, that is the gap, and closing it is a bookkeeping architecture job rather than a software purchase. We go through the structural side of that in more detail on our page covering cannabis accounting software and 280E bookkeeping.

What a dual-license dispensary should actually do

Four things, roughly in this order.

Check that your register can tell the two apart. The split has to originate at the point of sale. If your system cannot report medical and adult-use sales separately for every period, no accounting layer downstream can reconstruct it, and the whole allocation rests on nothing. This is worth verifying before you spend money anywhere else, and it is a legitimate reason to look at your platform choice again if the answer is no.

Pick an allocation basis and write down why. Operators commonly divide shared costs by square footage, by revenue share or by transaction counts. No single method is mandated. What carries weight is that the basis is reasonable for your actual facts, applied consistently period to period, documented when you adopt it rather than reconstructed later, and supported by underlying records. A defensible method chosen in advance beats a better method invented during an examination.

Keep the cost of goods sold discipline you built. There is a temptation to treat rescheduling as permission to relax. For the adult-use side, COGS remains the only lever you have, so every bit of inventory costing rigor still earns its keep. Shops that spent years building tight inventory accounting under 280E should keep all of that machinery running.

Make sure the documentation survives contact with a review. The allocation is the thing most likely to be tested, which means invoices, contracts and expense records need to be retrievable and legible years after the fact, not sitting in a shoebox or a shared drive nobody has indexed. Plenty of finance teams handle this by reconciling the register, the processor deposits and the bank feed automatically so the trail behind each allocated dollar is already assembled rather than rebuilt under deadline pressure.

Common questions

Is 280E going away entirely? Not on any confirmed timetable. It is gone for state-licensed medical operators as of April 2026. For adult-use it remains in force, and its future depends on the DEA proceeding whose briefing closed in August 2026, with no deadline for a decision. It is also worth remembering that 280E is a tax statute of general application, so it would continue to exist for other controlled substances regardless of what happens to cannabis.

Can I amend prior year returns? That is exactly the question to put to a cannabis-experienced accountant rather than the internet, because it turns on your entity, your filing history and guidance that is still being written. The rescheduling was not made retroactive to years before 2026, and the transition rule under discussion concerns the taxable year containing the effective date, not earlier ones.

Does this change anything about payments or banking? No. Card network rules prohibiting licensed cannabis retail are tied to federal law in a way rescheduling did not resolve, and a medical dispensary that gained real tax relief in April still cannot accept a Visa card. Those are separate problems with separate timelines, and conflating them is one of the most common mistakes in the industry right now. We cover the payments side, including the terminal shutdowns that hit thousands of shops this year, in our guide to cannabis payment processing for dispensaries.

What about CBD and hemp? Hemp containing 0.3% THC or less was never a Schedule I controlled substance, so 280E never applied to compliant hemp and CBD businesses and nothing changed for them in April. Intoxicating hemp products are a different and fast-moving question, and a business selling those should get specific advice rather than assuming the CBD answer covers it.

The short version

Schedule III ended 280E for state-licensed medical marijuana, effective April 28, 2026, with a transition rule expected to apply it to the full taxable year. It did not touch adult-use cannabis, which remains Schedule I and remains fully subject to 280E. For a recreational-only dispensary, nothing changed. For a medical-only dispensary, a great deal did. For the dual-license shops that make up much of the industry, the change created a real deduction and a real bookkeeping obligation to earn it, and the shops that get the structure right this year are the ones that will actually collect.

If you are rebuilding the systems underneath that split, the register is where it starts, and our comparison of dispensary POS systems and cannabis POS software covers which platforms report medical and adult-use sales separately. The wider budget picture, including where the accounting line sits against everything else, is in what dispensary software costs per month.